Impact of the reduction of environmental and equipment contamination on vancomycin-resistant enterococcus rates
Carregando...
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2011
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER HEIDELBERG
Autores
PERUGINI, M. R. E.
NOMI, S. M.
LOPES, G. K.
BELEI, R. A.
GRION, C.
Citação
INFECTION, v.39, n.6, p.587-593, 2011
Resumo
More than 1,500 perirectal swab cultures and 552 environmental and equipment cultures were collected during the study period. Enterococcus faecium was the most frequent species isolated, being responsible for 71% of the positive cultures. Fifty infections were documented, with bloodstream infections (18, 36%) being the most frequent, followed by urinary tract infection (15, 30%). An educational intervention was given to 136 healthcare workers (HCWs), and a questionnaire regarding vancomycin-resistant enterococcus (VRE) transmission was also performed pre-and post-intervention. Overall, 858 opportunities of patient care were evaluated. The compliance with contact precautions did not improve; however, in general, the proportion of correct answers regarding VRE increased significantly when comparing pre-and post-intervention periods (p < 0.05). On the other hand, the proportion of environmental and equipment contaminated by VRE decreased significantly from pre-(23.2%) to post-intervention (8.2%) (p < 0.001) and was associated with a significant decrease in VRE infection from 7.7 to 1.9 when comparing the pre-and post-intervention periods. The use of vancomycin (defined daily dose [DDD]) did not change significantly over the study period (p = 0.970), and the use of teicoplanin increased (p < 0.001). Seventy-six percent of E. faecium belong to type and subtype A by pulsed-field gel electrophoresis (PFGE). This predominant type was found in the environment and caused colonization and infection. In conclusion, the present study showed that reduction of the proportion of environmental and equipment contamination was associated with a decrease of colonization and infection due to VRE, and that the strategy to control VRE dissemination should be based on local problems.
Palavras-chave
Vancomycin-resistant enterococcus, Intensive care unit, Environment
Referências
- Hota B, 2009, J HOSP INFECT, V71, P123, DOI 10.1016/j.jhin.2008.10.030
- Slaughter S, 1996, ANN INTERN MED, V125, P448
- Yeh KM, 2004, MICROB DRUG RESIST, V10, P177, DOI 10.1089/1076629041310091
- Drees M, 2008, CLIN INFECT DIS, V46, P678, DOI 10.1086/527394
- Polk RE, 2007, CLIN INFECT DIS, V44, P664, DOI 10.1086/511640
- Grabsch EA, 2006, INFECT CONT HOSP EP, V27, P287, DOI 10.1086/503174
- Lin MY, 2010, CRIT CARE MED, V38, pS335, DOI 10.1097/CCM.0b013e3181e6ab12
- Puzniak LA, 2002, CLIN INFECT DIS, V35, P18, DOI 10.1086/340739
- Boyce JM, 2007, J HOSP INFECT, V65, P50, DOI 10.1016/S0195-6701(07)60015-2
- Gordin FM, 2005, INFECT CONT HOSP EP, V26, P650, DOI 10.1086/502596
- Lemmen SW, 2004, J HOSP INFECT, V56, P191, DOI 10.1016/j.jhin.2003.12.004
- Falk PS, 2000, INFECT CONT HOSP EP, V21, P575, DOI 10.1086/501806
- Hayden MK, 2006, CLIN INFECT DIS, V42, P1552, DOI 10.1086/503845
- Petrich AK, 1999, MOL CELL PROBE, V13, P275, DOI 10.1006/mcpr.1999.0250
- Duckro AN, 2005, ARCH INTERN MED, V165, P302, DOI 10.1001/archinte.165.3.302
- Martinez JA, 2003, ARCH INTERN MED, V163, P1905, DOI 10.1001/archinte.163.16.1905
- Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945
- Hayden MK, 2008, INFECT CONT HOSP EP, V29, P149, DOI 10.1086/524331
- GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3
- Bischoff WE, 2000, ARCH INTERN MED, V160, P1017, DOI 10.1001/archinte.160.7.1017
- Barbosa D, 2004, AM J KIDNEY DIS, V44, P337, DOI 10.1053/j.ajkd.2004.04.038
- Dalla Costa LM, 1998, BRAZ J INFECT DIS, V2, P160
- Eckstein BC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-61
- Furtado Guilherme Henrique Campos, 2005, Braz J Infect Dis, V9, P64, DOI 10.1590/S1413-86702005000100011
- Kuriyama T, 2003, J MED MICROBIOL, V52, P821, DOI 10.1099/jmm.0.05123-0
- Sheperd L., 2001, MORBIDITY MORTALITY, V4, P11
- Siegel JD, 2007, 2007 GUIDELINE ISOLA
- Tresoldi Antonia T, 2006, Braz J Infect Dis, V10, P239, DOI 10.1590/S1413-86702006000400004
- van Belkum A., 2007, CLIN MICROBIOL INFEC, V3, P1